Back

Red-flag signs and symptoms of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy in the TTRACK study

21 May 2023 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - epidemiology, prognosis, outcome 7 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Roberto Barriales-Villa

Coruna University Hospital Complex, Coruna, A (Spain)

6 More presentations in this session

Presentation thumbnail
Predicting mortality in patients with heart failure and obstructive chronic coronary syndrome
Doctor A. Kurasz (Bialystok, PL)
Abstract Slides
Presentation thumbnail
Ischemic etiology predicts poor prognosis in advanced heart failure: insight from the HELP-HF registry
Doctor A. Villaschi (Milan, IT)
Abstract Slides
Presentation thumbnail
Prevalence and determinants of pericardial effusion in the general population, Results from a population-based cohort study
Doctor F. Sahiti (Wurzburg, DE)
Abstract Slides
Presentation thumbnail
Rationale and design of the ESC EURObservational research programme heart failure III registry: implementation and discovery
Professor L. Lund (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Association between routinely reported symptoms and signs in heart failure and 3-month hospitalisation and mortality: a study in the UK general population of >85'000 heart failure patients
Mr M. Ali (Leicester, GB)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - epidemiology, prognosis, outcome 7

The Event

Event poster

Heart Failure 2023

21 May 2023 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources